- NCT00236756
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment100% Female45.9%% White86.7%
Product ClassAnticonvulsantsSponsor Protocol NumberYLData PartnerJohnson & JohnsonCondition StudiedEpilepsyMean/Median Age (Years)11.2
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available